Physician profile
Amy Grace
NPI 1154412625
$2,692.83
in general payments reported to CMS, 2019-2025
27 companies · $398 in 2025
The $398 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $159 · 2021: $352 · 2022: $527 · 2023: $574 · 2024: $458 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,403 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,403.26 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $635.70 | 2019-2025 | Slynd |
| Abbvie INC. | $445.87 | 2019-2022 | |
| Pfizer INC. | $279.93 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $250.16 | 2022-2025 | |
| Astellas Pharma US INC | $183.67 | 2023-2025 | Veozah |
| Intuitive Surgical, INC. | $129.39 | 2021-2023 | |
| Millicent US INC | $93.94 | 2023-2025 | Femring, Intrarosa, Femlyv |
| Mylan Pharmaceuticals INC. | $84.82 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.98 | 2020-2024 | |
| Therapeuticsmd, INC. | $61.00 | 2019-2021 | |
| Medtronic, INC. | $54.80 | 2025 | Truclear |
| Organon LLC | $48.71 | 2022-2024 | |
| Hologic Sales and Service, LLC | $47.05 | 2024-2025 | Myosure Tissue Removal Device, Aptima |
| Avion Pharmaceuticals | $41.91 | 2021 | |
| Aspira Women'S Health INC | $36.97 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $35.97 | 2023-2024 | Accrufer |
| Asensus Surgical, INC. | $27.87 | 2023 | Senhance |
| Coopersurgical, INC. | $27.78 | 2022 | |
| Dilon Technologies, INC. | $21.36 | 2024 | Hemoblast Bellows |
| Roche Diagnostics Corporation | $18.79 | 2019 | |
| Becton, Dickinson and Company | $16.79 | 2022 | |
| Smith+Nephew, INC. | $16.78 | 2025 | Pico 14 |
| Lsi Solutions INC | $15.89 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $14.44 | 2024 | |
| Evofem Biosciences, INC. | $12.73 | 2025 | Phexxi, Solosec, Phexx |
| Duchesnay USA Incorporated | $11.61 | 2019 | |
| Meditrina | $10.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Grace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.